日本臨床微生物学雑誌第22巻第3号

Similar documents
- 1 -

日本化学療法学会雑誌第61巻第6号

CHEMOTHERAPY aureus 0.10, Enterococcus faecalis 3.13, Escherichia coli 0.20, Klebsiella pneumoniae, Enterobacter spp., Serratia marcescens 0.78, Prote

Fig.1 Chemical structure of BAY o 9867

1272 CHEMOTHERAPY MAR. 1975

Fig.2. Sensitivity distribution of clinical isolates of S. epidermidis (24 strains, 106 CFU/ml) Staphylococcus aureus Staphylococcus epider- midis Ent

Key words: E. coli O 157: H7, fosfomycin, verotoxin, mouse infection

Key words: EHEC, VTEC, verotoxin, Shiga-like toxin

日本化学療法学会雑誌第64巻第4号

VOL.32 S-7 CHEMOTHERAPY Table 1 MIC of standard strains of CTRX Fig. 2 Cumulative curves of MIC S. aureus (26 strains )

THE JAPANESE JOURNAL OF ANTIBIOTICS 48-8 Enterococcus avium 5Š, Corynebacterium xerosis 10Š, Corynebacterium pseudodiphtheriticum 10Š, Corynebacterium

CHEMOTHERAPY NOV S. aureus, S. epidermidis, E. coli, K. pgeumoniae, E. cloacae, S. marcescens, P. mirabilis, Proteus, P. aeruginosa Inoculum siz

HPM_442_F_TgCHG_1128

CHEMOTHERAPY Methicillin-resistant S.aureus(MRSA) coccus epidermidis 105 Streptococcus pyogenes E.faecali senterococcus avium Enterococcus faecium Str

日本化学療法学会雑誌第58巻第4号

988 CHEMOTHERAPY NOV. 1971

CHEMOTHERAPY JUN Citrobacter freundii 27, Enterobacter aerogenes 26, Enterobacter cloacae 27, Proteus rettgeri 7, Proteus inconstans 20, Proteus

Key words: bacterial meningitis, Haemophilus influenzae type b, Streptococcus pneumoniae, rapid diagnosis, childhood

CHEMOTHERAPY JUNE 1987 Table1 Media used *BHIB, brain heart infusion broth (Difco); /3 -NAD, S -nicotinamidoadeninedinucleotide (Sigma Chemical Co.);

Key words: Antibodies to Leptospira, Tokyo, Uveitis

CHEMOTHERAPY FEB Table 1. Activity of cefpirome and others against clinical isolates

Staphylococcus sp. K.pneumoniae P.mirabilis C.freundii E. cloacae Serratia sp. P. aeruginosa ml, Enterococcus avium >100ƒÊg/ml

Table 1. Antibacterial activitiy of grepafloxacin and other antibiotics against clinical isolates

VOL. 23 NO. 3 CHEMOTHERAPY 1067 Table 2 Sensitivity of gram positive cocci isolated from various diagnostic materials Table 3 Sensitivity of gram nega

CHEMOTHERAPY DEC (NFLX), ofloxacin (OFLX), ciprofloxacin (CPFX) Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Enterococcus faecali

CHEMOTHERAPY APRIL 1992 Acinetobacter calcoaceticus Staphylococcus aureus, Escherichia coli P. aeruginosa E. eoli, Klebsiella pneumoniae Serratia marc


epidermidis, Enterococcus faecalis, Enterococcus Klebsiella pneumoniae, Proteus mirabilis, indolepositive Proteus spp., Enterobacter spp., Serratia

CHEMOTHERAPY JUNE 1993 Table 1. Background of patients in pharmacokinetic study


CHEMOTHERAPY Proteus mirabilis GN-79 Escherichia coli No. 35 Proteus vulgaris GN-76 Pseudomonas aeruginosa No. 11 Escherichia coli ML-1410 RGN-823 Kle


Key words: Streptococcus pyogenes, Streptococcus dysgalactiae subsp. equisimilis, rapid diagnosis

Key words: verocytotoxin-producing Escherichia coli, enterohemorrhagic Escherichia coli, Beutin' s blood agar

VOL.48 NO.7 lase negative staphylococci, Escherichia coli, Klebsiella spp., Citrobacter freundii, Enterobacter spp., indole-positive Proteus, Serratia

Shigella flexneri 2a, Shigella flexneri 3a, Shigella sonnei, Salmonella, Salmonella arizonae, Citorobacter freundii, Enterobacter aerogenes, Enterobac

Fig. 1 Chemical structure of DL-8280

Acecide_ProductsInformation2010PDF.indd


CHEMOTHERAPY




R06_01


CHEMOTHERAPY Fig. 1 Chemical structure of CXM-AX


CHEMO THE RAPY OCT. 1994

Key words:fatty acid,plant oil,staphylococcus aureus,skin care, atopic dermatitis

Table 1 Bacteriae to be tested (1) Gram positive cocci Coagulase positive staphylococcus Coagulase negative staphylococcus Streptococcus pneumoniae Gr

untitled

CHEMOTHERAPY JUNE 1986

Fig. 1 The sketch of the neonatal intensive care unit in Tokyo Women's Medical College Hospital. (1979)

Streptococcus pneumoniae,streptococcus pyogenes,streptococcus agalactiae,neisseria gonorrhoeae,h.influenzae,moraxella subgenus Branhamella catarrharis

VOL. 34 S-2 CHEMOTH8RAPY 913

Fig. 1 Trends of TB incidence rates for all forms and smear-positive pulmonary TB in Kawasaki City and Japan. Incidence=newly notified cases of all fo


Key words: Vibrio cholerae, TCBS agar

Key words: Disinfectants, Gram negative rods, Bactericidal effect P. aeruginosa 1, P. fluorescens 20 P. putida 179, P. cepacia 216 P. maltophilia 227,

coccus aureus Corynebacterium sp, Haemophilus parainfluenzae Klebsiella pneumoniae Pseudornonas aeruginosa Pseudomonas sp., Xanthomonas maltophilia, F

CHEMOTHERAPY

CHEMOTHERAPY


VOL. 43 NO. 4

THE JAPANESE JOURNAL OF ANTIBIOTICS 65 6 Dec DNA 2, , % 1.65% 1.17% 90% 9 Escherichia coli -

a) DifcoTM Brain Heart Infusion agar, DifcoTM Brain Heart Infusion, Becton, Dickinson and Company, U.S.A.

Key words: Surfactant, Tween, Legionella

Table 1 Characteristics of the study participants in Imari municipal hospital

pneumoniae 30, C. freundii 32, E. aerogenes 27, E. cloacae 32, P. mirabilis 31, P. vulgaris 34, M. morganii 32, S. marcescens 31, H. influenzae 27, P.

CHEMOTHERAPY Table 1 Clinical effect of Sultamicillin

Bacterial Contamination of Fresh Vegetables and Epidemiological Investigation of the Isolates Noriko KONISHI*1, Akemi KAI*l, Shigeru MATSUSHITA*1, Yay

農研機構研究報告 食品研究部門 第1号


ヒビスコール液A カタログ

Key words : 7432-S, Oral cephem, Urinary tract infection Fig. 1. Chemical structure of 7432-S.


Table 1. Antimicrobial drugs using for MIC

VOL.47 NO.5 Table 1. Susceptibility distribution of Ĉ- lactams against clinical isolates of MRSA MRSA: rnethicillin- resistant Staphylococcus aureus

CHEMOTHERAPY

320 Nippon Shokuhin Kagaku Kogaku Kaishi Vol. /., No.1, -,* -,/ (,**1) 8 * ** *** * ** *** E#ect of Superheated Steam Treatment on the Preservation an

Studies of Foot Form for Footwear Design (Part 9) : Characteristics of the Foot Form of Young and Elder Women Based on their Sizes of Ball Joint Girth

MIC MIC...

Nippon Suisan Gakkaishi 64(4), (1998) Biodegradation of Raw Silk in Seawater Akihiko Nakayama,*1,*3 Yoshihiro Inoue,*2 Yozo Tahara,*2,*4 Shozo

Table 1. Antibacterial spectrum SBT ABPC ABPC CPZ : sulbactamiampicillin : ampicillin : cefoperazone

37, 9-14, 2017 : cefcapene piperacillin 3 CT Clostridium difficile CD vancomycin CD 7 Clostridium difficile CD CD associate

Key words : candidemia, endotoxin, D-arabinitol, Candida antigen, serological examination

Fig. 1 Clinical findings and extent of inflammation area in female urethrocystitis Fig. 2 Classification and distribution of female patients with blad

Clostridium difficile ciprofloxacin, ofloxacin, norfloxacin Bifidobacterium Lactobacillus Lactobacillus Bacteroides fragilis B. fragilis C. difficile

第65回日本化学療法学会東日本支部総会 抄録



04-c-„FŒ{›xŒ¾-4.01

Visual Evaluation of Polka-dot Patterns Yoojin LEE and Nobuko NARUSE * Granduate School of Bunka Women's University, and * Faculty of Fashion Science,

スライド タイトルなし

THE JAPANESE JOURNAL OF ANTIBIOTICS ( 37 ) methicillin-susceptible Staphylococcus aureus (MSSA) Escherichia coli levof


Jan THE JAPANESE JOURNAL OF ANTIBIOTICS XL-1 Table 1. Outline of administering doses, routes and sampling times *: 4 ml/hr/kg Bacillus subtilis

2108 CHEMOTHERAPY SEPT Table 1 Antimicrobial spectrum Fig. 1

28 1 1a 1b 2 MRI T2 3 CT C3 N95 N95 6ml 90

Fig. 1 Chemical structure of KW-1070

Transcription:

2012 STEC 231 3 STEC 1) 1) 1) 2) 2) 3) 1) 2) 3) 24 3 6 24 7 19 (Enterohemorrhagic Escherichia coli; EHEC) STEC XM-EHEC 5S A /ViEHEC O157, O26, O111 3 STEC, 14.2 100, XM-EHEC, 7.1 85.7, ViEHEC, 27.6 100 EHEC STEC, 2.7, XM-EHEC, 19.8, ViEHEC, 25.6 STEC STEC 3 100 (O103 O121 O145) STEC EHEC Key words: STEC (Enterohemorrhagic Escherichia coli; EHEC) VT, stx EHEC 1) 4) O157 : H7 O26 : H11, O111 : H- O103, O121, O145 5) 20 6 18 0618005 940 2081 371 1 Tel: 0258 27 8500 Fax: 0258 27 8509 E-mail: nagaokanishi-lab275@sutokukai.or.jp EHEC O157 EHEC EHEC STEC XM-EHEC 5S A /ViEHEC EHEC STEC STEC (Lot No. 0T0921) XM-EHEC (Lot No. 008) 5S A /ViEHEC (Lot No.09004) EHEC EHEC 5S A /ViEHEC 5S A SS Vol. 22 No. 3 2012. 25

232 ViEHEC 316 Table 1 EHEC 225 O157; 86 O26; 38 O111; 18 O103; 7 O121; 8 O145; 5 EHEC 63 91 No. 2 35 24 1. 1 EHEC O157; ATCC35150 9 EHEC 9 O157 3 O26 3 O111 3 10 McFarland No. 0.5 10 μl 35 24 2. 1 EHEC O157; ATCC35150 9 EHEC 9 O157 3 O26 3 O111 3 10Miles & Misra 6 McFarland No. 0.5 10 100 μl 900 μl 10 10 1 10 9 20 μl Blue STEC, XM-EHEC, ViEHEC 35 24 2 3. 11 6 5 15 10 5 1 Miles & Misra 4. 1 (EHEC O157; ATCC35150) 3 EHEC 3 O157, O26, O111 4 10 2 10 4 CFU/g Blue 10 2 10 4 CFU/ml 0.5 ml 0.5 g 10 μl 35 24 5. 23 1 17 23 2 28 324 STEC, XM-EHEC, ViEHEC 10 μl EHEC EHEC / EHEC Ehly EHEC IKL LIM VP 7 Neg Combo 6.11J SIEMENS 6. STEC Table 1 316 STEC 10 μl 35 24 EHEC UV E-hly 7. 22 10 1623 6 11 228 829 EHEC STEC EHEC EHEC / Loopamp O 1. Fig. 1 STEC EHEC O157, EHEC O26, EHEC O111 EHEC O157 UV 26 Vol. 22 No. 3 2012.

STEC 233 Table 1. List of tested strains Strains Serover Origin VT N Subtotal EHEC Escherichia coli O157 : H7 O157 : H ATCC 35150 VT1, 2 1 VT1, 2 14 Isolates VT2 60 VT1 9 Isolates VT1, 2 1 VT2 1 O26 : H11 Isolates VT1, 2 1 VT1 30 VT1, 2 2 O26 : H Isolates VT1 5 O111 : H11 Isolate VT1 1 VT1, 2 4 O111 : H Isolates VT1 13 O103 : H Isolates VT1 2 O103 : H2 Isolates VT1 4 O103 : H11 Isolate VT1 1 O121 : H19 Isolates VT2 7 O121 : H14 Isolate VT2 1 O145 : H Isolates VT2 3 VT2 1 O145 : H NT Isolates VT1 1 Others* Isolates VT1, 2 3 VT2 18 VT1 42 ATCC 25922 1 O6 : H12 Isolates 2 O18 : H7 Isolate 1 O26 : H Isolate 1 O124 : H- Isolate 1 O157 : H Isolate 1 Klebsiella oxytoca ATCC13182 1 Klebsiella pneumoniae NCTC9636 1 Enterobacter cloacae ATCC13047 1 Citrobacter freundii ATCC8090 1 Proteus mirabilis ATCC29906 1 Pseudomonas aeruginosa ATCC27853 1 Bacillus subtilis ATCC6633 1 Staphylococcus aureus ATCC25923 1 Enterococcus faecalis ATCC29212 1 Candida albicans ATCC10231 1 Other bacteria** Isolates 74 Total 316 NT, not tested; OUT, 0-untypeable * O1 (2), O8 (1), O22 (1), O25 (1), O41 (1), O63 (3), O76 (2), O91 (26), O113 (2), O115 (4), O118 (1), O119 (1), O128 (1), O130 (1), O143 (1), O148 (1), O150 (1), O165 (7), OUT (5) ** Escherichia fergusonii (3), C. freundii (6), E. cloacae (53), Edwardsiella tarda (1), K. pneumoniae (1), K. oxytoca (1), Klebsiella ornithinolytica (1), P. mirabilis (1), Providencia rettegeri (1), P. aeruginosa (2), B. subtilis (1), S. aureus (1), E. faecalis (1), C. albicans (1) Vol. 22 No. 3 2012. 27 86 38 18 7 8 5 63 7 84

234 Fig. 1. Representative observation on CHROMagar STEC, XM-EHEC and ViEHEC EHEC O157 : H7 ATCC 35150, EHEC O26 : H11 isolate and EHEC O111 : H- isolate were incubated at 35 for 24 hours. 28 Vol. 22 No. 3 2012.

STEC 235 Table 2. Recovery rate of CHROMagar STEC, XM-EHEC and ViEHEC with Modified DRIGALSKI agar Blue Tested strains Recovery rate ( ) CHROM XM-EHEC ViEHEC EHEC O157 : H7 ATCC 35150 80.4 53.6 69.3 Isolate 1 14.2 7.1 27.6 Isolate 2 40.7 47.3 31.3 Isolate 3 94.4 83.3 100 EHEC O26 : H11 Isolate 1 77.2 24.1 79.7 Isolate 2 81.0 64.0 89.0 Isolate 3 100 85.7 85.7 EHEC O111 : H Isolate 1 100 57.5 97.5 Isolate 2 78.3 78.3 87.0 Isolate 3 54.7 49.3 56.0 Mean 72.1 55.0 72.3 CHROM, CHROMagar STEC XM-EHEC EHEC O157 EHEC O26 EHEC O111 ViEHEC O157 EHEC O26 EHEC O111 2. Table 2 STEC, XM-EHEC, ViEHEC EHEC O157 14.2 94.4, 7.1 83.3, 27.6 100, EHEC O26 77.2 100, 24.1 85.7, 79.7 89.0, EHEC O111 54.7 100, 49.3 78.3, 56.0 97.5 3. 3 STEC Enterobacter cloacae 1.1 10 5 CFU/ml O157 O26 4. Table 3 STEC XM-EHEC 10 2 10 3 CFU/g ViEHEC 10 2 CFU/g 10 5. EHEC STEC EHEC 9 2.7, XM-EHEC 64 19.8, ViEHEC 83 25.6 E-hly Table 4 XM-EHEC ViEHEC O111 10.5, 17.0 E. coli, Enterobacter Klebsiella 6. STEC (O157, O26, O111) EHEC STEC EHEC (O103, O121, O145) EHEC 63.5 ( Table 5) 7. EHEC EHEC 16 (0.007 ; 16/228,829) EHEC O157 1 (0.0004 ) EHEC O26 8 (0.0035 ) 7 (0.0031 ) EHEC O157 : H7 O26 : H11, O111 : H 3 3 XM-EHEC ViEH- EC E. coli Enterobacter Vol. 22 No. 3 2012. 29

236 Table 3. Detection of EHEC in fecal samples inoculated with EHEC O157, O26, or O111 Inoculated strains CFU/g (EHEC in feces) Detection from DRIGALSKI CHROM XM-EHEC ViEHEC EHEC O157 : H7 EHEC O26 : H11 EHEC O111 : H ATCC 35150 Isolate Isolate Isolate 3.8 10 2 Pos Pos (16) Pos (16) Neg 3.8 10 3 Pos Pos Pos Pos 3.8 10 4 Pos Pos Pos Pos 2.1 10 2 Pos Neg Neg Neg 2.1 10 3 Pos Pos (15) Pos (23) Pos (5) 2.1 10 4 Pos Pos Pos Pos 2.0 10 2 Pos Pos (10) Pos (11) Neg 2.0 10 3 Pos Pos Pos Pos 2.0 10 4 Pos Pos Pos Pos 2.0 10 2 Pos Pos (20) Pos (5) Neg 2.0 10 3 Pos Pos Pos Pos 2.0 10 4 Pos Pos Pos Pos CHROM, CHROMagar STEC; DRIGALSKI, Modified DRIGALSKI agar Blue; Pos, Positive; Neg, Negative The numbers in parenthesis are the numbers of colonies from evaluated culture media. Table 4. Detection rate and enterohemolysin production of EHEC-like colonies in fecal samples N 324 Colony color of CHROMagar STEC XM-EHEC ViEHEC Mauve MUG ( ) Mauve, MUG ( ) Violet Blue Pale pink/ Pink Clear/ Brown Green/ Blue Pale pink/ Violet Escherichia coli 1 4 3 1 2 3 2 14 Enterobacter cloacae 1 7 9 1 15 E. agglomerans 3 2 4 Klebsiella pneumoniae 1 6 12 1 13 K. oxytoca 7 5 1 5 Citrobacter spp. 1 3 1 4 Proteus mirabilis 1 1 P. vulgaris 1 7 Pseudomonas aeruginosa 2 6 Pseudomonas spp. 4 Acinetobacter spp. 1 Staphylococcus aureus 1 Subtotal ( ) 4 (1.2) 5 (1.5) 29 (9.0) 1 (0.3) 34 (10.5) 25 (7.7) 3 (0.9) 55 (17.0) Total ( ) 9 (2.7) 64 (19.8) 83 (25.6) Enterohemolysis ( ) 0 (0.0) 0 (0.0) 0 (0.0) MUG, 4-methylumbelliferyl-β-d-glucuronide;, positive;, negative Klebsiella 19.8, 25.6 STEC EHEC EHEC O157, O26, O103, O111, O121, O145 5) STEC (Table 5) 30 Vol. 22 No. 3 2012.

STEC 237 Strain Table 5. Colony observation of EHEC on CHROMagar STEC and enterohemolysin agar Mauve MUG( ) Colony observation Enterohemolysis Mauve, No growth Blue Clear Pos Neg MUG( ) EHEC O157 86 86 0 EHEC O26 38 38 0 EHEC O111 18 18 0 EHEC O103 7 7 0 EHEC O121 8 8 0 EHEC O145 5 5 0 Other EHEC 23 40 63 0 Other Escherichia coli 2 5 0 7 Other bacteria 3* 1** 80 4 80 MUG, 4-methylumbelliferyl-β-d-glucuronide;, positive; -, negative; Pos, Positive; Neg, Negative * Enterobacter cloacae (2), Citrobacter freundii (1) ** Escherichia hermanii (1) 2010 EHEC O157 1,078 EHEC O26 305 EHEC 211 67.6, 19.1, 13.2EHEC O157 1 (0.0004 ) EHEC O26 8 (0.0035 ) EHEC 7 (0.0031 ) EHEC O157 CT-SMAC EHEC O157 EHEC 8) 9) STEC 9 EHEC enterohemolysis EHEC 63.5 EHEC eaea 10) Fukushima EHEC eaea EHEC CT- SMAC 11) (O157, O26, O111, O103, O121, O145) Tzschoppe STEC terb 12) STEC CT-SMAC (data not shown) 2010 (stx) O104 O104 50 4,400 STEC Tzschoppe 12 stx VT1/VT2 ELISA Loopamp EHEC EHEC 13) STEC EHEC EHEC Vol. 22 No. 3 2012. 31

238 STEC 1) Edelman, R., M. A. Karmali, P. A. Fleming. 1988. From the National Institutes of Health. Summary of the International Symposium and Workshop on Infections due to Verocytotoxin (Shiga-like toxin)-producing Escherichia coli. J. Infect. Dis. 157: 1102 1104. 2) Karmali, M. A., M. Petric, C. Lim, et al. 1985. The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli. J. Infect. Dis. 151: 775 782. 3) Pai, C. H., N. Ahmed, H. Lior, et al. 1988. Epidemiology of sporadic diarrhea due to verocytotoxin-producing Escherichia coli: A two-year prospective study. J. Infect. Dis. 157: 1054 1057. 4) Riley, L. W., R. S. Remis, S. D. Helgerson, et al. 1983. Hemorrhagic colitis associated with a rare Escherichia coli serotype. N. Engl. J. Med. 308: 681 685. 5) Gyles, C. L. 2007. Shiga toxin-producing Escherichia coli: An overview. J. Anim. Sci. 85: E45 E62. 6) 1978 p. 201 210, 7) 1991. p. 1 178. 8) Beutin, L., M. Montenegro, I. Φrskov, et al. 1989. Close association of verotoxin (shiga-like toxin) production with enterohemolysin production in strains of Escherichia coli. J. Clin. Microbiol. 27: 2559 2564 9) 2002 4 5: 85 88 10) 2010 p. 17 21. 11) Fukusima, H., K. Hiroshina, M. Gomyoda. 2000. Selective isolation of eae-positive strains of shigatoxinproducing Eschericha coli. J. Clin. Microbiol. 38: 1684 1687. 12) Tzschoppe, M., A. Martin, L. Beutin. 2012. A rapid procedure for the detection and isolation of enterohaemorrhagic Escherichia coli (EHEC) serogroup O26, O103, O111, O118, O121, O145 and O157 strains and the aggregative EHEC O104: H4 strain from ready-to-eat vegetables. Int. J. Food. Microbiol. 152: 19 30. 13) 2010 O26 O157 (SEL) 20: 33 40. Comparison of Three Chromogenic Culture Medium for Differentiation of Enterohemorrhagic Escherichia coli (EHEC), and Availability of CHROMagar STEC for EHEC Carrier-Screening Yuuki Sumiya, 1) Masanori Umezawa, 1) Hiroshi Yamazaki, 1) Mitsuru Okamoto, 2) Mizuho Hayashida, 2) Takamasa Kaneko 3) 1) Nagaoka-Nishi Hospital 2) Tokyo Kenbikyoin Foundation 3) Kanto Chemical Co., Inc. Chromogenic medium CHROMagar STEC and XM-EHEC and ViEHEC were evaluated as selective isolation media for enterohemorrhagic Escherichia coli (EHEC). The growth support abilities (percentages) of three sera groups mainly in Japan (O157, O26, O111) were 14.2 100 in CHROMagar STEC, 7.1 85.7 in XM-EHEC, and 27.6 100 in ViEHEC. The EHEC-similar colony appearance rates in fecal samples were 2.7 in CHROMagar STEC, 19.8 in XM- EHEC, and 25.6 in ViEHEC. These findings indicated that CHROMagar STEC showed the highest specificity for EHEC. The detection sensitivity of CHROMagar STEC for the main three sera groups was 100. Moreover, outbreaks have been reported, and mauve colonies were formed in all tested strains with O157, O26, O111, O103, O121, and O145, which are believed to be highly associated with disease. These results indicated that CHROMagar STEC had sufficiently high sensitivity and specificity that it would be suitable medium on the theme of carrier-screening for EHEC. 32 Vol. 22 No. 3 2012.